All entries for: Oncology
May 10, 2023
Pfizer
Neutral Outlook
New York, NY
50,001+ employees
50001+ employees
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule
May 10, 2023
Context Therapeutics
Negative Outlook
Philadelphia, PA
1-50 employees
1-50 employees
Disease Area: Oncology
Drug Type: Biologic
May 9, 2023
Xilio Therapeutics
Negative Outlook
Waltham, MA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Biologic
May 9, 2023
Adicet Bio
Negative Outlook
Boston, MA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Biologic
May 9, 2023
IDEAYA Biosciences
Negative Outlook
San Francisco, CA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 9, 2023
Halozyme Therapeutics
Negative Outlook
San Diego, CA
201-500 employees
201-500 employees
Disease Area: Oncology
Drug Type: Biologic
May 9, 2023
Exelixis
Negative Outlook
Alameda, CA
1,001-5,000 employees
1001-5000 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 9, 2023
CytomX Therapeutics
Negative Outlook
San Francisco, CA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Biologic
May 8, 2023
Zymeworks
Negative Outlook
Middletown, DE
201-500 employees
201-500 employees
Disease Area: Multiple, Oncology, Therapeutics
Drug Type: Biologic
May 8, 2023
Recursion Pharmaceuticals
Neutral Outlook
Salt Lake City, UT
201-500 employees
201-500 employees
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule